Preoperative PSA velocity and doubling time do not predict adverse pathologic features or biochemical recurrence after radical prostatectomy
- 1 March 2001
- Vol. 57 (3), 476-480
- https://doi.org/10.1016/s0090-4295(00)01016-5
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Multivariate analysis of race and adverse pathologic findings after radical prostatectomyUrology, 2000
- Race is not an independent predictor of biochemical recurrence after radical prostatectomy in an equal access medical centerUrology, 2000
- Early prostate-specific antigen relapse after radical retropubic prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristics.European Urology, 1999
- A Preoperative Nomogram for Disease Recurrence Following Radical Prostatectomy for Prostate CancerJNCI Journal of the National Cancer Institute, 1998
- PRETREATMENT PROSTATE SPECIFIC ANTIGEN DOUBLING TIMES: USE IN PATIENTS BEFORE RADICAL PROSTATECTOMYJournal of Urology, 1997
- Role of prostate-specific antigen velocity in prediction of final pathologic stage in men with localized prostate cancerUrology, 1997
- Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional updatePublished by American Medical Association (AMA) ,1997
- Pretreatment prostate-specific antigen doubling times: clinical utility of this predictor of prostate cancer behaviorInternational Journal of Radiation Oncology*Biology*Physics, 1996
- Effect of cystoscopy, prostate biopsy, and transurethral resection of prostate on serum prostate-specific antigen concentrationUrology, 1993
- Evaluation of Radical Prostatectomy SpecimensThe American Journal of Surgical Pathology, 1992